Literature DB >> 19012810

Enhanced latent inhibition in dopamine receptor-deficient mice is sex-specific for the D1 but not D2 receptor subtype: implications for antipsychotic drug action.

Cecilie Bay-Richter1, Colm M P O'Tuathaigh, Gerard O'Sullivan, David M Heery, John L Waddington, Paula M Moran.   

Abstract

Latent inhibition (LI) is reduced learning to a stimulus that has previously been experienced without consequence. It is an important model of abnormal allocation of salience to irrelevant information in patients with schizophrenia. In rodents LI is abolished by psychotomimetic drugs and in experimental conditions where LI is low in controls, its expression is enhanced by antipsychotic drugs with activity at dopamine (DA) receptors. It is however unclear what the independent contributions of DA receptor subtypes are to these effects. This study therefore examined LI in congenic DA D1 and D2 receptor knockout (D1 KO and D2 KO) mice. Conditioned suppression of drinking was used as the measure of learning in the LI procedure. Both male and female DA D2 KO mice showed clear enhancement of LI reproducing antipsychotic drug effects in the model. Unexpectedly, enhancement was also seen in D1 KO female mice but not in D1 KO male mice. This sex-specific pattern was not replicated in locomotor or motor coordination tasks nor in the effect of DA KOs on baseline learning in control groups indicating some specificity of the effect to LI. These data suggest that the dopaminergic mechanism underlying LI potentiation and possibly antipsychotic action may differ between the sexes, being mediated by D2 receptors in males but by both D1 and D2 receptors in females. These data suggest that the DA D1 receptor may prove an important target for understanding sex differences in the mechanisms of action of antipsychotic drugs and in the aetiology of aberrant salience allocation in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012810      PMCID: PMC2760776          DOI: 10.1017/S1461145708009656

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  72 in total

Review 1.  The pharmacology of latent inhibition as an animal model of schizophrenia.

Authors:  P C Moser; J M Hitchcock; S Lister; P M Moran
Journal:  Brain Res Brain Res Rev       Date:  2000-09

Review 2.  Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models.

Authors:  Jingshan Chen; Barbara K Lipska; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2006-05-02       Impact factor: 13.382

3.  Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.

Authors:  Segev Barak; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2006-09-13       Impact factor: 7.853

Review 4.  Latent inhibition: the nucleus accumbens connection revisited.

Authors:  J A Gray; P M Moran; G Grigoryan; S L Peters; A M Young; M H Joseph
Journal:  Behav Brain Res       Date:  1997-10       Impact factor: 3.332

5.  Differential performance of acute and chronic schizophrenics in a latent inhibition task.

Authors:  I Baruch; D R Hemsley; J A Gray
Journal:  J Nerv Ment Dis       Date:  1988-10       Impact factor: 2.254

6.  Clinical features of latent inhibition in schizophrenia.

Authors:  C Rascle; O Mazas; G Vaiva; M Tournant; O Raybois; M Goudemand; P Thomas
Journal:  Schizophr Res       Date:  2001-09-01       Impact factor: 4.939

Review 7.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

8.  An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states.

Authors:  R de Beaurepaire; A Labelle; D Naber; B D Jones; T R Barnes
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

9.  Effects of the selective dopamine D(1) antagonists NNC 01-0112 and SCH 39166 on latent inhibition in the rat.

Authors:  Karen M Trimble; Robert Bell; David J King
Journal:  Physiol Behav       Date:  2002-09

Review 10.  Effects of estrogen on the basal ganglia.

Authors:  C Van Hartesveldt; J N Joyce
Journal:  Neurosci Biobehav Rev       Date:  1986       Impact factor: 8.989

View more
  9 in total

1.  Dopamine receptor mediation of the exploratory/hyperactivity effects of modafinil.

Authors:  Jared W Young; Klaas Kooistra; Mark A Geyer
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

2.  Aberrant Salience Is Related to Reduced Reinforcement Learning Signals and Elevated Dopamine Synthesis Capacity in Healthy Adults.

Authors:  Rebecca Boehme; Lorenz Deserno; Tobias Gleich; Teresa Katthagen; Anne Pankow; Joachim Behr; Ralph Buchert; Jonathan P Roiser; Andreas Heinz; Florian Schlagenhauf
Journal:  J Neurosci       Date:  2015-07-15       Impact factor: 6.167

Review 3.  Sex differences in animal models of psychiatric disorders.

Authors:  N Kokras; C Dalla
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

4.  Dopamine D1 receptor involvement in latent inhibition and overshadowing.

Authors:  Andrew J D Nelson; Karen E Thur; Helen J Cassaday
Journal:  Int J Neuropsychopharmacol       Date:  2011-12-16       Impact factor: 5.176

Review 5.  Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission.

Authors:  Sean C Godar; Marco Bortolato
Journal:  Front Behav Neurosci       Date:  2014-03-06       Impact factor: 3.558

6.  Potentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2)-deficient mice: do antipsychotics influence learning to ignore irrelevant stimuli via both Drd-2 and non-Drd-2 mechanisms?

Authors:  Matthew J O'Callaghan; Cecilie Bay-Richter; Colm Mp O'Tuathaigh; David M Heery; John L Waddington; Paula M Moran
Journal:  J Psychopharmacol       Date:  2014-08-13       Impact factor: 4.153

7.  Specialized Information Processing Deficits and Distinct Metabolomic Profiles Following TM-Domain Disruption of Nrg1.

Authors:  Colm M P O'Tuathaigh; Naina Mathur; Matthew J O'Callaghan; Lynsey MacIntyre; Richard Harvey; Donna Lai; John L Waddington; Benjamin S Pickard; David G Watson; Paula M Moran
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

8.  D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors.

Authors:  C Bay-Richter; M J O'Callaghan; N Mathur; C M P O'Tuathaigh; D M Heery; K C F Fone; J L Waddington; P M Moran
Journal:  Neuropsychopharmacology       Date:  2013-02-19       Impact factor: 7.853

Review 9.  From attention to memory along the dorsal-ventral axis of the medial prefrontal cortex: some methodological considerations.

Authors:  Helen J Cassaday; Andrew J D Nelson; Marie A Pezze
Journal:  Front Syst Neurosci       Date:  2014-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.